Global Pet Oral Dewormers Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pet Oral Dewormers Market Research Report 2024
Pet oral dewormers are medications specifically formulated for dogs and cats to treat and prevent infestations of internal parasites, such as roundworms, hookworms, whipworms, and tapeworms, that can reside in the digestive tract. These dewormers come in the form of oral tablets, chewables, or liquids, and they are administered by mouth to effectively eliminate and control various types of intestinal parasites.
Pet oral dewormers play a crucial role in maintaining the health and well-being of dogs and cats by preventing the negative effects of internal parasites.
According to Mr Accuracy reports’s new survey, global Pet Oral Dewormers market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pet Oral Dewormers market research.
Key manufacturers engaged in the Pet Oral Dewormers industry include Pfizer (Zoetis), Bayer HealthCare Animal Health, Boehringer Ingelheim Vetmedica, Novartis, Elanco Animal Health, Beaphar, Merck, Spectrum Brands (ProSense) and PetIQ (Sentry, Petarmor), etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Pet Oral Dewormers were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pet Oral Dewormers market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pet Oral Dewormers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Pfizer (Zoetis)
Bayer HealthCare Animal Health
Boehringer Ingelheim Vetmedica
Novartis
Elanco Animal Health
Beaphar
Merck
Spectrum Brands (ProSense)
PetIQ (Sentry, Petarmor)
Durvet
Ramical
Virbac
Segment by Type
Oral Tablets
Chewables
Liquids
Dogs
Cats
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pet Oral Dewormers report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Pet oral dewormers play a crucial role in maintaining the health and well-being of dogs and cats by preventing the negative effects of internal parasites.
According to Mr Accuracy reports’s new survey, global Pet Oral Dewormers market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pet Oral Dewormers market research.
Key manufacturers engaged in the Pet Oral Dewormers industry include Pfizer (Zoetis), Bayer HealthCare Animal Health, Boehringer Ingelheim Vetmedica, Novartis, Elanco Animal Health, Beaphar, Merck, Spectrum Brands (ProSense) and PetIQ (Sentry, Petarmor), etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Pet Oral Dewormers were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Pet Oral Dewormers market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pet Oral Dewormers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer (Zoetis)
Bayer HealthCare Animal Health
Boehringer Ingelheim Vetmedica
Novartis
Elanco Animal Health
Beaphar
Merck
Spectrum Brands (ProSense)
PetIQ (Sentry, Petarmor)
Durvet
Ramical
Virbac
Segment by Type
Oral Tablets
Chewables
Liquids
Segment by Application
Dogs
Cats
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pet Oral Dewormers report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices